QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序作者升序作者降序提交时间升序提交时间降序题名升序题名降序 Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 会议论文 BLOOD, 2018-11-29 作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03 Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from t 期刊论文 2018, 卷号: 132 作者:  Fu, Weijun;  Lu, Jin;  Jin, Jie;  Xu, Yan;  Wu, Depei 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: Analysis from the Asia Lymphoma Study Group 期刊论文 EUROPEAN JOURNAL OF CANCER, 2013, 卷号: 49, 期号: 16 作者:  Kim, Seok Jin;  Hsu, Chiun;  Song, Yu-Qin;  Tay, Kevin;  Hong, Xiao-Nan 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Hepatitis B virus  Rituximab  B-cell  Lymphoma   Chronic myeloid leukemia in the Asia-Pacific region: Current practice, challenges and opportunities in the targeted therapy era 期刊论文 LEUKEMIA RESEARCH, 2010, 卷号: 34, 期号: 11 作者:  Kim, Dong-Wook;  Banavali, Shripad D.;  Bunworasate, Udomsak;  Goh, Yeow-Tee;  Ganly, Peter 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Asia  Clinical practice  CML  Imatinib  Management  Survey  TKI